TIL – instil bio, inc. (US:NASDAQ)
Stock Stats
News
Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? [Yahoo! Finance]
Summit boosts Instil, BioNTech as lead drug beats Merck's Keytruda [Seeking Alpha]
Futures Gain As Expectations For A 50bps Rate Cut Spike [zero hedge]
Private equity firms are Instil Bio, Inc.'s (NASDAQ:TIL) biggest owners and were rewarded after market cap rose by US$52m last week [Yahoo! Finance]
Form SC 13G/A Instil Bio, Inc. Filed by: Boxer Capital Management, LLC
Form SC 13D/A Instil Bio, Inc. Filed by: Curative Ventures V LLC
Form SC 13G Instil Bio, Inc. Filed by: Boxer Capital, LLC
Form SC 13G Instil Bio, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Form 4 Instil Bio, Inc. For: Sep 18 Filed by: Laumas Sandeep
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.